about
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expressionCirculating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies.Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathyInfluence of cigarette smoking on thyroid gland--an update.Insulin resistance in pregnancy complicated by type 1 diabetes mellitus. Do we know enough?Advances in the pharmacological treatment of Graves' orbitopathy.Time-dependent irisin concentration changes in patients affected by overt hypothyroidism.Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level.The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.Hindgut neuroendocrine neoplasms - characteristics and prognosis.Connection between bone remodeling and inflammatory markers in obstructive sleep apnea in relation to disease severityThyPROpl--The Polish version of the thyroid-specific quality of life questionnaire ThyPRO.GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.New lower cutoff for serum high sensitive C-reactive protein in obese women indicates the risk of metabolic syndrome.The role of free triiodothyronine in pathogenesis of infertility in levothyroxine-treated women with thyroid autoimmunity - a preliminary observational study.Pasireotide - mechanism of action and clinical applications.Red cell distribution width - a new marker for exacerbation of heart failure in patients with hypothyroidism following radioiodine therapy.Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies.[The impact of cannabinoids on the endocrine system].Association of total, acylated and unacylated ghrelin with apolipoprotein A1 and insulin concentrations in acromegalic patients
P50
Q36162234-2FD84CEF-426D-431D-9AA7-8B6D790009BAQ36538245-A77ECA29-38A5-4747-8B50-2FC8F82118BCQ37104648-C88E22E6-034A-47AF-A517-B7AB89264437Q38189278-0A95EAF2-F281-44C2-80E7-FBE9BF7CF636Q38446475-BB123107-BAD8-420E-A7D2-52441278A2F1Q38769722-C63E14C9-DF41-4B1F-8F09-5F6569F268D7Q39991990-E9D4D640-D428-4EA2-994F-E3E4B4CCD2A7Q41858962-D9D2142E-9742-4318-AEF0-2B6650048E0FQ41902145-F0A9D363-3DC0-4468-BAF0-195F664E75B9Q47104431-32863AFC-2517-4F27-BD13-707ADEDE8C45Q47431155-FAB21C2F-1CBD-433A-9B26-A2E7E48D2917Q47976659-52E45691-D96A-4AE4-A8EE-7255FE57A3AEQ47976672-AA2E204B-F31B-41F9-900E-B3A9EF1044E5Q49382897-590DE881-DFFF-4E53-ABAF-12D490A3A856Q51110072-D8BCDAFE-AFD1-498D-83F9-53EFC6EDA77EQ51732889-2AEB674D-EC9A-41CF-AF3F-5D6953F251E7Q52674395-0383473F-D72D-4ED3-937F-24DC8E06F249Q52726197-9F9E376E-D9A7-4701-9012-0676E5286B6AQ54225092-82C5EE82-FB12-42B6-B692-1023893800A8Q92472398-3A1F852C-D152-4649-A010-2B31BB500CBD
P50
description
Polish endocrinologist
@en
Pools arts
@nl
inchríneolaí Polannach
@ga
polska lekarka, endokrynolog
@pl
name
Nadia Sawicka-Gutaj
@ast
Nadia Sawicka-Gutaj
@en
Nadia Sawicka-Gutaj
@es
Nadia Sawicka-Gutaj
@ga
Nadia Sawicka-Gutaj
@nl
Nadia Sawicka-Gutaj
@pl
Nadia Sawicka-Gutaj
@sl
type
label
Nadia Sawicka-Gutaj
@ast
Nadia Sawicka-Gutaj
@en
Nadia Sawicka-Gutaj
@es
Nadia Sawicka-Gutaj
@ga
Nadia Sawicka-Gutaj
@nl
Nadia Sawicka-Gutaj
@pl
Nadia Sawicka-Gutaj
@sl
prefLabel
Nadia Sawicka-Gutaj
@ast
Nadia Sawicka-Gutaj
@en
Nadia Sawicka-Gutaj
@es
Nadia Sawicka-Gutaj
@ga
Nadia Sawicka-Gutaj
@nl
Nadia Sawicka-Gutaj
@pl
Nadia Sawicka-Gutaj
@sl
P214
P101
P106
P1412
P1559
Nadia Sawicka-Gutaj
@pl
P21
P214
P27
P31
P3124
P496
0000-0003-1510-4702
P735
P7859
viaf-308780830